This compound, a 1,5-benzothiazepin-4(5H)-one derivative, acts as a weak inhibitor of GSK-3beta with an IC50 exceeding 100 µM. It serves as a useful research tool for investigating GSK-3beta signaling pathways in cellular models of neurological disorders and diabetes.
Molekulargewicht:
283.39
Reinheit:
99.97% (May vary between batches)
CAS Nummer:
[863004-48-2]
Formel:
C17H17NOS
Target-Kategorie:
GSK-3
Anwendungsbeschreibung:
Solubility: DMSO:2.88 mg/mL (10.16 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten